MDRX.US Veradigm Inc.

Healthcare Health Care Technology USA Stocks
4.74 USD
Close of Nov 14, 2026
3.25 5.60
Market cap
USD 517M
P/E
-
P/B
0.68x
ROE
-8.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2024.

Is MDRX.US undervalued?

Graham number

The Graham number of Veradigm Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Veradigm Inc. fundamental analysis

No fundamental analysis for Veradigm Inc. yet.

Veradigm Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Veradigm Inc.

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include e…

Full company profile